Hong Kong Drug Licence Applications and Acquisitions · RGYS|Global Licensing and Compliance Service Provider
Hong Kong pharmaceutical compliance · applications / acquisitions / ongoing maintenance Independent Third-Party Service Provider
HONG KONG DRUG LICENSING

What approval procedures must I follow if I plan to relocate my pharmaceutical warehouse?

A complete explanation of the regulatory basis, Drew Tang’s recommendations and risk alerts. The original material dates from 2025; read it alongside the latest official requirements.

Original guide, 2025 edition: These FAQs are provided for topic-based reference and have not all been individually checked against current rules. Please confirm fees, personnel, renewal, changes and product requirements against the professional in-depth guide for the relevant licence type and the official requirements in force at the time.

Drug Office, Department of Health Chinese Medicines Board

Q237 · Category E: Application Process and Approval Procedures (Q201-Q250)
If you plan to relocate your pharmaceutical warehouse, this is a major change and you must not simply “move first and report later”. You must treat it as a new “mini” licence application. The correct procedure is as follows: first, preferably have a professional consultant assess the new premises for compliance before signing a tenancy agreement. You then need to submit a formal “Change of Premises” application to the Drug Office, Department of Health. This application must include detailed plans of the new premises, the tenancy agreement and a statement explaining why relocation is necessary. The Department of Health will conduct a full on-site inspection of the new premises as it would for a new application. You may only start moving medicines to the new address after the new premises has passed inspection and you have received formal written approval from the Department of Health for the change of address. Until approval is granted, you must continue operating at your existing licensed address.

📘 Regulatory basis

Your medicine licence is tied to a specific licensed address. Storing or wholesaling medicines at an unapproved address is equivalent to operating without a licence. The Code of Practice for Wholesale Dealers also expressly requires prior approval from the Department of Health for any significant change to the premises.

📗 Drew Tang's recommendations

We will manage the entire relocation process for you. From selecting the new premises and designing the layout plan to submitting a change application to the Department of Health and preparing the new premises for an on-site inspection, we will support you throughout. We will also help you plan a seamless relocation to ensure that your business operations and compliance status are not affected during the transition to the new address.

📕 Risk notice

The greatest risk is “moving first and notifying later”. If you move medicines to a new address without approval, the Department of Health may immediately suspend or even revoke your licence if it discovers this. This is an absolute red line. Another risk is signing a new lease without adequate assessment, only to find that the new premises cannot meet compliance requirements, leaving you in a dilemma.

Back to Category E: Application Process and Approval Procedures (Q201-Q250) Search more questions

YOUR NEXT STEP

Plan Your Hong Kong Pharmaceutical Licensing Project with Drew Tang

Business Manager Tang Shangyong (Drew Tang) will review your products, operating model, licence type and preparation requirements with you one-to-one. The precise service scope is confirmed in writing; pharmaceutical duties are carried out by legally qualified personnel, and approvals are determined by the competent authorities.

Book a Project Assessment ↗